Market Highlights
Global Hemodynamic Monitoring System Market is expected to register a CAGR of 6.48% during the forecast period and hit USD 2,024.43 Million by 2027.
The development of technologically advanced minimally invasive or non-invasive products for the hemodynamic monitoring system has increased its sales in-home care settings and clinics. The minimally invasive monitoring systems help in tracking stroke volume and offer dynamic information of fluid responsiveness. Some of the systems provide the evaluation of volumetric preload variables, while others highlight the continuous volume of central venous saturation with proprietary catheters. These variables of minimally invasive systems, along with cardiac output, deliver improved hemodynamic monitoring.
The rising prevalence of cardiovascular disorders diabetes, increasing demand for home-based and non-invasive monitoring systems, and technological advancements are anticipated to drive the global hemodynamic monitoring system market share. In September 2019, Baxter International Inc. entered into a definitive agreement to acquire Cheetah Medical, a leading non-invasive hemodynamic monitoring technology provider. The agreement demonstrates Baxter's ongoing commitment to improving clinical outcomes with an established patient monitoring technology to inform and guide clinicians about various treatments. Similarly, in December 2018, Edwards Lifesciences Corporation announced that the HemoSphere advanced hemodynamic monitoring platform received the US FDA’s clearance for the Acumen suite of intelligent decision-support solutions.
Segment Analysis
Global Hemodynamic Monitoring System Market has been divided based on Type, Product, and End User.
types of hemodynamic monitoring, has been segregated into invasive, minimally invasive, and non-invasive hemodynamic monitoring systems.
Based on product, the global hemodynamic monitoring system market is segmented into hemodynamic monitoring systems and disposables.
On the basis of end user, the market is bifurcated into hospitals clinics, ambulatory care centers, and others.
Regional Analysis
Global Hemodynamic Monitoring System Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East Africa. The Americas is likely to hold the largest share of the global hemodynamic monitoring system market during the high prevalence of cardiovascular diseases diabetes, product launch, and acquisition in this region. The Europe market is expected to register substantial growth in the market due to the organic growth strategies of companies and a well-developed medical industry in the region. Asia-Pacific is likely to hold the third-largest share of the global hemodynamic monitoring system market. The market in the Middle East Africa is expected to witness gradual growth owing to the rising prevalence of cardiac disorders and diabetes, increasing in the number of critically ill geriatric cases, advances in technology, funding by private players and government bodies, increasing demand for home-based and non-invasive monitoring systems, and rising number of people suffering from hypertension.
Hemodynamic Monitoring Systems Market Players
- Edwards Lifesciences Corporation,
- Getinge AB,
- Baxter International Inc.,
- Drägerwerk AG Co. KGaA,
- LiDCO Group,
- Osypka Medical GmbH,
- Deltex Medical,
- ICU Medical,
- CNSYSTEMS MEDIZINTECHNIK GMBH,
- NI Medical.
among others are some key companies in the global Hemodynamic Monitoring Systems that are listed by MRFR for market research.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
